Latest

Dec 13, 2017
Pharmaceutical Executive
Pharm Exec details the latest approaches to combating disease and health crises on a global scale—including industry perspectives from those involved on the front lines.
Dec 12, 2017
Pharmaceutical Executive
Amid a widening net of health threats worldwide, alliances forged in research and response may be more critical than ever to stem the tide.
Dec 12, 2017
Pharmaceutical Executive
Figuring out the right formula to address global health—for the better.
Dec 11, 2017
Pharmaceutical Executive
Groundbreaking treatment approaches call for innovative commercialization strategies.
Dec 10, 2017
Pharmaceutical Executive
Drawing from his research roots and the leadership lessons gained in melding business and culture in geographies across the globe, Ruud Dobber is busy steering AstraZeneca’s US course as it navigates the complexities of a fast-evolving therapeutic market.
Dec 01, 2017
The Chinese government's “Healthy China” plan presents an unprecedented opportunity for the US healthcare industry and its investors, writes Steven Shill.
Nov 30, 2017
Paul Meade and Mark Schoeman describe the determining factor driving effective relationships between medical science liaisons and key opinion leaders.
Nov 10, 2017
Before entering into risk-sharing agreements, manufacturers must understand the challenges and implications, writes Kimberly E. White.
Nov 03, 2017
Pharmaceutical Executive
Agency leaders go slow in weighing changes to DTC ads and off-label marketing. Jill Wechsler reports.
Nov 01, 2017
Pharmaceutical Executive
This article explores the difficult nature of developing drugs for rare diseases and discusses what a pharmaceutical executive can actively do to help increase success.
native1_300x100
lorem ipsum